Sofinnova Investments related stories
All articles and analysis
Sorbent Therapeutics Soaks Up $36M Series BSorbent Therapeutics, the California-based biopharmaceutical company, took $36 million from a group of VCs, the company announced. Investors include Novartis Venture Funds, which led the financing, joining existing investors Sofinnova Ventures, ARCH Venture Partners, CMEA Capital and AgeChem. The deal brings Sorbent’s total funding to $53 million.
- Osage Zeroes in on University Startups
Philadelphia-area firm raises $100M for its debut effort
In Memoriam: Jean DeleageCo-founder of Alta Partners was 70
- Aerie Pharmaceuticals Closes $30M Series B
Aerie Pharmaceuticals Inc., a biotechnology company focused on medical innovations in ophthalmology, has closed $30 million in Series B financing. Clarus Ventures and Sofinnova Ventures co-led the round, with participation from Osage University Partners and existing investors Alta Partners and TPG Biotech. Aerie Pharmaceuticals has offices in Research Triangle Park, N.C. and in Bridgewater, N.J.
- NextWave Pharmaceuticals Secures $45 Million in Financing
NextWave Pharmaceuticals Inc. secured $45 million in a Series C financing, which was co-led by new investors Panorama Capital o Menlo Park, Calif., and Bay City Capital LLC of San Francisco, Calif. Kearny Venture Partners and current investors: Aisling Capital, Fidelity Biosciences, Sofinnova Ventures and Vivo Ventures participated in the round. NextWave plans to use the capital to commercialize its NEXICLON™ XR product for the treatment of hypertension, to expand the CNS portfolio and to prepare for introduction of a novel extended-release liquid methylphenidate for Attention Deficit Hyperactivity Disorder.
- Sofinnova Ventures Names Garheng Kong A General Partner
Sofinnova Ventures named Garheng Kong a general partner. Kong will invest in biopharmaceutical companies from the firm's SVP VII fund. Kong was previously general partner at Intersouth Partners, where he worked for 10 years.
- peHUB Wire: Wednesday, September 8, 2010
Editor’s Note: Today’s guest column comes from Randy Schwimmer of mid-market lender Churchill Financial.
- peHUB Wire: Wednesday, September 8, 2010
Editor’s Note: Today’s guest column comes from Randy Schwimmer of mid-market lender Churchill Financial.
- Exit watch, week of July 19, 2010
News briefs about acquisitions involving VC-backed companies FusionOne, Wize and others